|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03309 C-MER MEDICAL
Nominal 
1.690 +0.010 (+0.595%) | 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 1,913,162 | -0.561% | 1,923,964 | 1,731,903 | 1,112,577 | 699,545 |
| Cost of Sales | (1,385,543) | 6.172% | (1,305,002) | (1,284,206) | (754,349) | (505,468) |
| Gross Profit | 527,619 | -14.757% | 618,962 | 447,697 | 358,228 | 194,077 |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (128,442) | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (975) | -- | 3,164 | 37,799 | 10,652 | (276) | |
| Profit / (Loss) before Taxation | (76,221) | -- | 124,269 | (11,227) | 26,875 | 2,504 | |
| Taxation | (32,093) | -15.398% | (37,934) | (34,998) | (10,645) | (10,916) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (26,849) | 10.322% | (24,337) | 24,350 | 5,631 | 2,166 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (135,163) | -- | 61,998 | (21,875) | 21,861 | (6,246) | |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | 9,085 | -- | (1,768) | 12,544 | 8,520 | 5,296 |
| Depreciation & Amortisation | 213,623 | -3.334% | 220,990 | 224,034 | 148,581 | 113,562 |
| Directors' Emoluments | -- | -- | 11,966 | 12,777 | 14,079 | 9,118 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -10.960 | -- | 4.940 | -1.770 | 1.900 | -0.570 |
| DPS (cts) | 2.000 | -- | 0.000 | 0.000 | 0.000 | 2.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.288 | 0.134 | 0.126 | 0.099 |
| NBV per share ($) | 1.396 | -- | 1.470 | 1.473 | 1.157 | 1.128 |
| Remarks: | Real time quote last updated: 30/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -135,163 |
| %Change | -- |
| EPS / (LPS) | HKD -0.110 |
| NBV Per Share ($) | HKD 1.396 |